Skip to main content
PharmaResearch Co., Ltd. logo

PharmaResearch Co., Ltd. — Investor Relations & Filings

Ticker · 214450 ISIN · KR7214450009 KO Manufacturing
Open in API
Filings indexed 258 across all filing types
Latest filing 2025-01-15 Regulatory Filings
Country KR South Korea
Listing KO 214450

About PharmaResearch Co., Ltd.

https://pharmaresearch.co.kr/en/

PharmaResearch Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. It utilizes marine biotechnology to develop and commercialize refined raw materials for cell and tissue regeneration. The company's activities also encompass the manufacturing of medical devices and providing consulting services for the development, licensing, and registration of pharmaceuticals. PharmaResearch focuses on creating innovative biological products to enhance human health and quality of life.

Recent filings

Filing Released Lang Actions
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the adjustment of contract amounts and sales figures for a previously disclosed supply agreement. Since this is a specific regulatory disclosure regarding a material contract update and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2025-01-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the National Pension Service's change in shareholding of PharmaResearch. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2025-01-06 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from PharmaResearch regarding the setting of a record date for shareholder registry closure for the purpose of dividend distribution. It specifies the record date (2024-12-31) and the purpose (determining shareholders for the 24th fiscal year dividend). While it mentions dividends, it is not the final declaration of the dividend amount itself, but rather the procedural announcement of the record date. Given the nature of the announcement as a regulatory disclosure regarding corporate action, it fits best under the 'Notice of Dividend Amount' (DIV) category as it pertains to the dividend process.
2024-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the record date. Given its nature as a regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2024-12-16 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Corporate Day) hosted by PharmaResearch. It details the date, location, purpose, and participants of the event. Since it is an announcement of an event and the availability of IR materials rather than the presentation slides themselves, it falls under the category of a regulatory filing announcement regarding corporate events.
2024-11-29 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for PharmaResearch, detailing quarterly financial performance (revenue, operating profit, net income) for Q3 2024. It provides key financial highlights and is explicitly labeled as provisional data (잠정치) that has not been audited. This fits the definition of an Earnings Release (ER), which is the initial announcement of periodic financial results. Q3 2024
2024-11-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.